Drug intelligence / Profile preview

polidocanol + sodium tetradecyl sulphate

Development stage
Approved
Lead developer
Merz
Modality
Small Molecules
Administration
Intravenous, Intralesional, Percutaneous
01

Overview

The combination of polidocanol and sodium tetradecyl sulphate (STS) consists of two distinct detergent sclerosing agents used primarily in the treatment of varicose veins, telangiectasias, and venous malformations. Polidocanol is a non-ionic detergent, while sodium tetradecyl sulphate is an anionic detergent. Both agents function by inducing local endothelial damage through the disruption of cell membranes (detergent action). This chemical irritation triggers platelet aggregation, thrombus formation, and subsequent inflammation, eventually leading to the replacement of the vessel with fibrous tissue (sclerosis) and permanent closure. In clinical practice, this combination is often employed in 'dual sclerotherapy' or as a compounded mixture to enhance efficacy in larger or more resistant vessels compared to monotherapy with either agent alone.

Other names
lauromacrogol 400 + sodium tetradecyl sulphateSTS + polidocanol

Beyond the preview

Go deeper on polidocanol + sodium tetradecyl sulphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polidocanol + sodium tetradecyl sulphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call